Evolutionary Genomics, Inc. (FNAM)
Evolutionary Genomics, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Castle Rock, CO, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,331. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of -0.12 implies it has historically moved less than the broad market.
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Evolutionary Genomics, Inc. is most often compared with the following Healthcare names: